- Home
- NXC vs FORA Comparison
NXC vs FORA Comparison
Compare NXC & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXC
- FORA
- Stock Information
- Founded
- NXC 1992
- FORA 2014
- Country
- NXC United States
- FORA United States
- Employees
- NXC N/A
- FORA N/A
- Industry
- NXC Investment Managers
- FORA Computer Software: Prepackaged Software
- Sector
- NXC Finance
- FORA Technology
- Exchange
- NXC Nasdaq
- FORA Nasdaq
- Market Cap
- NXC 82.6M
- FORA 77.6M
- IPO Year
- NXC N/A
- FORA N/A
- Fundamental
- Price
- NXC $13.10
- FORA $2.41
- Analyst Decision
- NXC
- FORA Strong Buy
- Analyst Count
- NXC 0
- FORA 1
- Target Price
- NXC N/A
- FORA $5.00
- AVG Volume (30 Days)
- NXC 17.5K
- FORA 57.0K
- Earning Date
- NXC 01-01-0001
- FORA 03-27-2025
- Dividend Yield
- NXC 3.97%
- FORA N/A
- EPS Growth
- NXC N/A
- FORA N/A
- EPS
- NXC 0.19
- FORA N/A
- Revenue
- NXC N/A
- FORA $19,709,723.00
- Revenue This Year
- NXC N/A
- FORA N/A
- Revenue Next Year
- NXC N/A
- FORA $13.59
- P/E Ratio
- NXC $70.47
- FORA N/A
- Revenue Growth
- NXC N/A
- FORA N/A
- 52 Week Low
- NXC $11.86
- FORA $1.96
- 52 Week High
- NXC $13.70
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- NXC 48.44
- FORA 48.34
- Support Level
- NXC $13.00
- FORA $2.35
- Resistance Level
- NXC $13.19
- FORA $4.03
- Average True Range (ATR)
- NXC 0.09
- FORA 0.45
- MACD
- NXC -0.00
- FORA -0.01
- Stochastic Oscillator
- NXC 25.64
- FORA 19.00
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing primarily in municipal obligations.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.